BAMF Health 2025 Highlights and Impact
2025 was more than a year of milestones; it was a year of impact. A year of bold advances, compassionate care, and lives touched.
Read more
November 28, 2025
News and Articles
BAMF Health Doses First Patient in Promising New Prostate Cancer Alpha Radioligand Therapy Clinical Trial
BAMF Health dosed the first patient enrolled in a Phase 1 prostate cancer therapy clinical trial sponsored by ARTBIO.
Read more
November 25, 2025
It Takes Courage. God Gave Me Courage.
With a zest and appreciation for life, at 77 years old, Barbara considered herself the picture of perfect health. But that changed in June of 2025 when she was diagnosed with metastatic HR-/HER2+ breast cancer.
Read more
October 2, 2025
East River Medical Imaging Selected as First BAMF RadioNexus Site in the New York City Area
Partnership brings new cancer trial and treatments to patients in New York City and Westchester.
Read more
September 9, 2025
What We’re Learning about Pre-Chemotherapy Treatment with Pluvicto®
We’re among the first centers in the country to treat patients in the new “pre-chemo” setting. Here’s what we’re learning—and what we’re still working to understand.
Read more
September 2, 2025
Join the BAMF Health 108 Walk for Prostate Cancer
Join us this September as we raise awareness for prostate cancer by walking 108 miles!
Read more
August 18, 2025
BAMF Health, Ferris State, KentISD expand partnership to accelerate high schoolers’ path toward innovative STEM careers
Enrollment for this year’s FutureSolve program is nearly double last year’s.
Read more
July 6, 2025
BAMF Health Launches National Clinical Trials Platform, BAMF RadioNexus, and Enrolls National Health System
RadioNexus is the world’s first radiopharmaceutical-focused clinical trials network.
Read more
June 18, 2025
Prostate Cancer Patients Now Have an Option Other Than Chemotherapy
Prostate cancer patients whose cancer has spread have a game-changing new option for treatment.
Read more
May 12, 2025
BAMF Health Doses First Patient in the U.S. in Phase 2b Imaging Study of Brain Metastasis
BAMF Health dosed the first patient in the U.S. for Radiopharm Theranostics’ Phase 2b imaging study of 18F-RAD101 in suspected recurrent brain metastasis.
Read more
April 28, 2025
BAMF Health seeks breast cancer patients for groundbreaking imaging study
This non-invasive clinical trial aimed to understand the prevalence of a specific biomarker in HR-/HER2+ breast cancer.
Read more
April 24, 2025
Celebrating World Theranostics Day 2025
BAMF Health Chief Medical Advisor Dr. Harshad Kulkarni shares his expert perspectives on the field of Theranostics and where it’s headed.
Read more
March 28, 2025
A Holiday Health Scare Leads to Rare Discovery
Mike credits the radiopharmaceutical therapy he received at BAMF for shrinking his neuroendocrine tumor and saving his life.
Read more
March 27, 2025
Reeling in a Brighter Future
After a decades-long battle with neuroendocrine cancer, Nolan hopes treatment at BAMF Health will stop his cancer in its tracks.
Read more
March 24, 2025